04.03.26 -- Scaling Regenerative Medicine Production With PolarityBio's Nikolai Sopko

Understand data management and process automation challenges across single-use bioprocessing applications from a CDMO leader.

Explore the application of a platform in creating CHO cell lines for manufacturing multi-chain biologics, emphasizing the uniformity of the pools generated in terms of titer and the rapid selection of these pools.

Discover a simple yet powerful solution for getting viral clearance studies done safely, thoroughly, efficiently, and on your timelines, as well as how to free your teams and trust your project.

 In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Nikolai Sopko, MD, Ph.D., chief operating officer, chief scientific officer, and director at PolarityBio, a biotech company developing SkinTE, an investigational autologous regenerative skin therapy for diabetic ulcers.

How can modular yet universal freezing technologies improve the product quality of your active pharmaceutical ingredients during cold chain logistics?

Master the complexities of aseptic gowning and Annex 1 compliance. Examine risk-based strategies to mitigate human-source contamination and strengthen your facility's sterility assurance.